Package 63323-413-36

Brand: neostigmine methylsulfate

Generic: neostigmine methylsulfate
NDC Package

Package Facts

Identity

Package NDC 63323-413-36
Digits Only 6332341336
Product NDC 63323-413
Product ID 63323-413_1efedce1-b2c3-4652-a289-6ea596b039e2
Description

10 VIAL, MULTI-DOSE in 1 TRAY (63323-413-36) / 10 mL in 1 VIAL, MULTI-DOSE

Marketing

Marketing Status
Marketed Since 2015-01-08
Brand neostigmine methylsulfate
Generic neostigmine methylsulfate
Sample Package No

Linked Drug Pages (1)

Neostigmine Methylsulfate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "1efedce1-b2c3-4652-a289-6ea596b039e2", "openfda": {"upc": ["0363323413361"], "unii": ["98IMH7M386"], "rxcui": ["311935", "311936"], "spl_set_id": ["d0e11e4c-41c3-4874-b567-579db655fba3"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, MULTI-DOSE in 1 TRAY (63323-413-36)  / 10 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "63323-413-36", "marketing_start_date": "20150108"}], "brand_name": "Neostigmine Methylsulfate", "product_id": "63323-413_1efedce1-b2c3-4652-a289-6ea596b039e2", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "63323-413", "generic_name": "Neostigmine Methylsulfate", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Neostigmine Methylsulfate", "active_ingredients": [{"name": "NEOSTIGMINE METHYLSULFATE", "strength": ".5 mg/mL"}], "application_number": "NDA203629", "marketing_category": "NDA", "marketing_start_date": "20150108", "listing_expiration_date": "20261231"}